Related Experiment Video
Updated: Aug 11, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Association Between the Relative Duration of Sliding Scale Insulin Use and the Length of Hospital Stay in
Hanna Osawa1, Kelechi Obi2, Mahbubur Rahman2
1Department of Education and Training, St. Luke's International Hospital, Japan.
Abstract:
Objective To examine the association between the proportion of hospitalizations managed with sliding-scale insulin and inpatient outcomes in non-critically ill patients with type 2 diabetes mellitus. Patients and Methods We conducted a retrospective cohort study of 595 hospitalized patients with previously diagnosed type 2 diabetes mellitus who initially received sliding-scale insulin (SSI) for glycemic management and were subsequently transitioned to scheduled insulin therapy prior to discharge. The primary outcome was the length of hospital stay (LOS), and the secondary outcomes included intensive care unit (ICU) transfer and in-hospital mortality. The nonlinearity between the SSI/LOS and outcomes was assessed using quadratic regression. Based on the identified inflection point, patients were stratified into SSI/LOS ≤50% and SSI/LOS >50% groups. Results SSI/LOS demonstrated a non-linear, U-shaped association with the length of stay, with the shortest length of stay observed at 47% (adjusted R2=0.408). Both the lower and higher SSI/LOS values were associated with longer hospitalizations. The results were robust to adjustments for glycemic variability and sensitivity analysis using the absolute SSI duration. Conclusion Relative SSI exposure during hospitalization was nonlinearly associated with LOS. Inpatient insulin management patterns, rather than SSI use alone, may be associated with the hospital course.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type I Diabetes III: Clinical Manifestations
Type II Diabetes II: Pathophysiology